Hong Jin | Nano-Materials | Distinguished Scientist Award

Hong Jin | Nano-Materials | Distinguished Scientist Award

Prof. Dr. Hong Jin, Xi’an Jiaotong University, China.

Jafar Ezzati Nazhad Dolatabadi | Nanotechnology | Best Researcher Award

Jafar Ezzati Nazhad Dolatabadi | Nanotechnology | Best Researcher Award

Assoc. Prof. Dr. Jafar Ezzati Nazhad Dolatabadi, Tabriz University of Medical Sciences, Iran.

Dr. Jafar Ezzati Nazhad Dolatabadi is an Associate Professor at Tabriz University of Medical Sciences, specializing inΒ pharmaceutical nanotechnologyΒ πŸ§ͺ. With a strong background inΒ biochemistryΒ andΒ molecular research, he has contributed extensively to nanomedicine, drug delivery systems, and cancer therapy 🎯. His research involves synthesizing and characterizingΒ nanocarriersΒ for drug delivery,Β cytotoxicity studies, andΒ biophysical interactions. Dr. Dolatabadi has authored numerous publications inΒ renowned journalsΒ πŸ“–Β and presented atΒ international conferences 🌍. His ongoing research focuses onΒ biosensors and molecular imprintingΒ for medical and environmental applications.

Publication Profiles

Scopus

Education & ExperienceΒ πŸŽ“πŸ’Ό

βœ…Β B.Sc. in Biology – Iran 🧬
βœ…Β M.Sc. in Biochemistry – Razi UniversityΒ πŸ§ͺ
βœ…Β Ph.D. in Pharmaceutical Nanotechnology – Tabriz University of Medical SciencesΒ πŸ’Š
βœ…Β Associate ProfessorΒ atΒ Tabriz University of Medical SciencesΒ since 2014Β πŸ‘¨β€πŸ«
βœ…Β Published extensivelyΒ in international journalsΒ πŸ“‘
βœ…Β Presented researchΒ at global conferences 🌎

Summary Suitability

Dr. Jafar Ezzati Nazhad Dolatabadi, an Associate Professor at Tabriz University of Medical Sciences, has made exceptional contributions to the field of Pharmaceutical Nanotechnology. With a robust academic foundation and extensive experience in researching drug delivery systems, nanomedicine, and anticancer therapies, Dr. Dolatabadi’s work stands out for its profound impact on improving therapeutic strategies. His innovative research in designing and characterizing novel drug formulations, along with his emphasis on nanocarriers for enhanced drug delivery, has earned him recognition and accolades in the scientific community. His dedication to advancing the field of pharmaceutical sciences makes him a deserving candidate for the Best Researcher Award.

Professional DevelopmentΒ  πŸ“šπŸ”

Dr. Dolatabadi has significantly contributed to biomedical research with a focus on pharmaceutical nanotechnology πŸ§ͺ, drug delivery πŸ’Š, and cancer therapy πŸŽ—οΈ. He has worked on nanolipidic carriers, biomolecular interactions, and cytotoxicity studies to improve targeted drug formulations. His expertise extends to surface plasmon resonance, spectroscopy, and molecular imprinting for biosensing applications πŸ”. With over 20 research projects completed, his innovations aid in drug safety, targeted therapies, and environmental health monitoring 🌱. His current research integrates nanotechnology with electrochemical biosensors, enhancing medical diagnostics and food safety testing πŸ₯.

Research Focus

Dr. Jafar Ezzati Nazhad Dolatabadi’s research focuses on pharmaceutical nanotechnology πŸ§ͺ, with an emphasis on drug delivery systems πŸ’Š, cancer therapies πŸŽ—οΈ, and biomolecular interactions πŸ”¬. His work involves developing nanolipidic carriers, dendrimers, and polymeric systems to improve drug bioavailability and targeting. He explores cytotoxicity and genotoxicity studies 🧬 to assess the safety of pharmaceuticals and food additives 🍽️. Additionally, he is working on biosensors for detecting contaminants in food and the environment 🌱, using techniques like surface plasmon resonance for real-time molecular interaction analysis. His research bridges medicine, biotechnology, and environmental science 🌍.

Awards & Honors πŸ†πŸŽ–

πŸ…Β International Research AwardsΒ in Pharmaceutical NanotechnologyΒ πŸ§ͺ
πŸ…Β Best Research Paper AwardsΒ in Nanomedicine & BiophysicsΒ πŸ“œ
πŸ…Β Recognized at International ConferencesΒ for Biochemical Research 🌎
πŸ…Β Recipient of Prestigious GrantsΒ for Drug Delivery InnovationsΒ πŸ’°
πŸ…Β Academic Excellence AwardΒ for Contributions to Biomedical ScienceΒ πŸ†

Publications Top Noted

  • “Targeted co-delivery nanosystem based on methotrexate, curcumin, and PAMAM dendrimer for improvement of the therapeutic efficacy in cervical cancer.” Scientific Reports 🌐.
  • “Functionalizing of magnetic nanoparticles as nano-architecture towards bioimaging and colorimetric recognition of MCF-7 cells: dual opto-sensing and fluorescence monitoring for early-stage diagnosis of breast cancer.” Mikrochimica Acta πŸ§ͺ.
  • “PAMAM dendrimers based co-delivery of methotrexate and berberine for targeting of Hela cancer cells.” Toxicology Reports βš—οΈ. 1 citation.
  • “Applications of Advanced Nanomaterials in Biomedicine, Pharmaceuticals, Agriculture, and Food Industry.” BioNanoScience 🧬. 5 citations.
  • “Probing amikacin interaction with albumin: A combined multispectral and molecular docking investigation.” Heliyon 🧫. 0 citations.
  • “Cytotoxic and genotoxic effects of tert-butylhydroquinone, butylated hydroxyanisole and propyl gallate as synthetic food antioxidants.” Food Science and Nutrition 🍏. 4 citations.
  • “Polysaccharide-based sensors and nanosensors: A review of recent progress and challenges.” Microchemical Journal πŸ§ͺ. 2 citations.
  • “Probing binding mode between sodium acid pyrophosphate and albumin: multi-spectroscopic and molecular docking analysis.” Journal of Biomolecular Structure and Dynamics 🧬. 2 citations.